Rob Nerenz, PhD |
Fig. 01 -
Title Slide
Fig. 02 -
Disclosure
Fig. 03 -
DHMC Background
Fig. 04 -
Study Objective
Fig. 05 -
Study Design
Fig. 06 -
TSI/TRAb Methods
Fig. 07 -
QC
Fig. 08 -
QMC: Roche
Fig. 09 -
QMC: Siemens
Fig. 10 -
Discordant Results
Fig. 11 -
DR: Part 1
Fig. 12 -
DR: Part 2
Fig. 13 -
DR: Part 3
Fig. 14 -
Endogenous Interference
Fig. 15 -
Non-Linear
Fig. 16 -
TRAb/TSI Result
Fig. 17 -
Practical Considerations
Fig. 18 -
Take-Home Points
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.